NKIRAS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.463200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.836000E-01
Normal-vs-Stage2
9.300000E-01
Normal-vs-Stage3
6.027000E-01
Normal-vs-Stage4
4.724200E-01
Stage1-vs-Stage2
2.124000E-01
Stage1-vs-Stage3
2.148000E-01
Stage1-vs-Stage4
5.458000E-01
Stage2-vs-Stage3
5.421400E-01
Stage2-vs-Stage4
3.270800E-01
Stage3-vs-Stage4
2.829400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.210000E-01
Normal-vs-AfricanAmerican
7.127200E-01
Normal-vs-Asian
6.517000E-01
Caucasian-vs-AfricanAmerican
9.653000E-01
Caucasian-vs-Asian
2.905400E-01
AfricanAmerican-vs-Asian
3.292800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.142000E-01
Normal-vs-Female
7.687400E-01
Male-vs-Female
4.150000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.031000E-01
Normal-vs-Age(41-60Yrs)
5.105400E-01
Normal-vs-Age(61-80Yrs)
9.412800E-01
Normal-vs-Age(81-100Yrs)
4.113800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.258200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.936800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.901800E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.034580E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.536270E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.807800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.859000E-01
Normal-vs-Daily Drinker
5.892800E-01
Normal-vs-Weekly Drinker
7.927200E-01
Normal-vs-Occasional Drinker
7.186000E-01
Normal-vs-Social Drinker
6.976800E-01
Non Drinker-vs-Daily Drinker
9.787600E-01
Non Drinker-vs-Weekly Drinker
2.504200E-01
Non Drinker-vs-Occasional Drinker
2.003600E-01
Non Drinker-vs-Social Drinker
1.576590E-01
Daily Drinker-vs-Weekly Drinker
2.548400E-01
Daily Drinker-vs-Occasional Drinker
2.013000E-01
Daily Drinker-vs-Social Drinker
1.620550E-01
Weekly Drinker-vs-Occasional Drinker
6.882800E-01
Weekly Drinker-vs-Social Drinker
8.176200E-01
Occasional Drinker-vs-Social Drinker
8.160000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.055400E-01
Normal-vs-Grade 2
7.884200E-01
Normal-vs-Grade 3
7.555800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.921560E-01
Grade 1-vs-Grade 3
9.722000E-02
Grade 1-vs-Grade 4
8.055400E-01
Grade 2-vs-Grade 3
2.867600E-01
Grade 2-vs-Grade 4
7.884200E-01
Grade 3-vs-Grade 4
7.555800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.688200E-01
Normal-vs-NonDiabetic
8.617800E-01
Diabetic-vs-NonDiabetic
1.326010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.601600E-01
Normal-vs-NoPancreatitis
8.935200E-01
Pancreatitis-vs-NoPancreatitis
6.255000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.786000E-01
Normal-vs-N1
9.779200E-01
N0-vs-N1
9.728100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.084200E-01
Normal-vs-TP53-NonMutant
3.809400E-01
TP53-Mutant-vs-TP53-NonMutant
1.675700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
